Stimulation of β-adrenoceptors inhibits endotoxin-induced IL-12 production in normal and IL-10 deficient mice

Journal of Neuroimmunology

Volumn 88, Issue 1-2, 1998, Pages 57-61

  Haskó, György ^a   Szabó, Csaba ^a,b   Németh, Zoltán H ^a   Salzman, Andrew L ^b   Vizi, E Sylvester ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

adrenoreceptors; Cytokines; Dexamethasone; Lipopolysaccharide; Murine

Indexed keywords

BETA ADRENERGIC RECEPTOR; CATECHOLAMINE; DEXAMETHASONE; ENDOTOXIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; ISOPRENALINE; LIPOPOLYSACCHARIDE; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTOXEMIA; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

ADRENERGIC BETA-AGONISTS; ANIMALS; ENDOTOXINS; INTERLEUKIN-10; INTERLEUKIN-12; ISOPROTERENOL; MALE; MICE; MICE, INBRED BALB C; RECEPTORS, ADRENERGIC, BETA; REFERENCE VALUES;

EID: 0032146334     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00073-3     Document Type: Article

References (32)

1. + T cells via CD40 ligand. Proc. Natl. Acad. Sci. USA 94, 599-603.
2. Berg, D.J., Kühn, R., Rajewsky, K., Müller, W., Menon, S., Davidson, N., Grünig, G., Rennick, D., 1995. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J. Clin. Invest. 96, 2339-2347.
3. Brosnan, C.F., Raine, C.S., 1996. Mechanisms of immune injury in multiple sclerosis. Brain Pathol. 6, 243-257.
4. Elenkov, I.J., Haskó, G., Kovács, K.J., Vizi, E.S., 1995. Modulation of lipopolysaccharide-induced tumor necrosis factor-α production by selective α- and β-adrenergic drugs in mice. J. Neuroimmunol. 61, 123-131.
5. Elenkov, I.J., Papanicolau, D.A., Wilder, R.L., Chrousos, G.P., 1996. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. P. Assoc. Am. Physicians 108, 1-8.
6. Gantner, F., Küsters, S., Wendel, A., Hatzelmann, A., Schudt, C., Tiegs, G., 1997. Protection from T cell-mediated murine liver failure by phosphodiesterase inhibitors. J. Pharmacol. Exp. Ther. 280, 53-60.
7. 2-adrenoreceptors on plasma levels of tumour necrosis factor-α, interleukin-6 and corticosterone induced by bacterial lipopolysaccharide in mice. J. Endocrinol. 144, 457-462.
8. Haskó, G., Szabó, C., Németh, Z.H., Kvetan, V., Pastores, S.M., Vizi, E.S., 1996. Adenosine receptor agonists differentially regulate IL-10, TNF-α, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J. Immunol. 157, 4634-4640.
9. Haskó, G., Németh, Z.H., Szabó, C., Zsilla, G., Salzman, A.L., Vizi, E.S., 1998a. Isoproterenol inhibits IL-10, TNF-α, and nitric oxide production in RAW 264.7 macrophages. Brain Res. Bull. 45, 183-187.
10. Haskó, G., Szabó, C., Németh, Z.H., Salzman, A. L, Vizi, E.S., 1998b. Suppression of interleukin-12 production by phosphodiesterase inhibition in murine endotoxemia is interleukin-10 independent. Eur. J. Immunol. 28, 468-472.
11. Heinzel, F.P., Rerko, R.M., Ling, P., Hakimi, J., Schoenhaut, D.S., 1994. Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon. Infect. Immun. 62, 4244-4249.
12. Hu, X., Goldmuntz, E.A., Brosnan, C.F., 1991. The effect of norepinephrine on endotoxin-mediated macrophage activation. J. Neuroimmunol. 31, 35-42.
13. Ignatowski, T.A., Spengler, N., 1995. Regulation of macrophage-derived tumor necrosis factor production by modification of adrenergic receptor sensitivity. J. Neuroimmunol. 61, 61-70.
14. G-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs. Crit. Care Med. 22, 1835-1840.
15. Le Moine, O., Stordeur, P., Schandené, L., Marchant, A., de Groote, D., Goldman, M., Deviere, J., 1996. Adenosine enhances IL-10 secretion by human monocytes. J. Immunol. 156, 4408-4414.
16. Leonard, J.P., Waldburger, K.E., Goldman, S.J., 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181, 381-386.
17. Németh, Z.H., Haskó, G., Szabó, C., Vizi, E.S., 1997. Amrinone and theophylline differentially regulate cytokine and nitric oxide production in endotoxemic mice. Shock 7, 371-375.
18. Nicoletti, F., Patti, F., Cocuzza, C., Zaccone, P., Nicoletti, A., Di Marco, R., Reggio, A., 1996. Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis. J. Neuroimmunol. 70, 87-90.
19. Ozmen, L., Pericin, M., Hakimi, J., Chizzonite, R.A., Wysocka, M., Trinchieri, G., Gately, M., Garotta, G., 1994. Interleukin-12, interferon γ, and tumor necrosis factor α are the cytokines of the generalized Shwartzman reaction. J. Exp. Med. 180, 907-915.
20. Park, J.-H., Shin, S.-H., 1996. Induction of IL-12 gene expression in the brain in septic shock. Biochem. Biophys. Res. Commun. 224, 391-396.
21. Pastores, S.M., Hasko, G., Vizi, E.S., Kvetan, V., 1996. The role of vasoactive drugs in the regulation of cytokine production in sepsis. New Horiz. 4, 252-264.
22. Rott, O., Fleischer, B., Cash, E., 1994. Interleukin-10 prevents experimental allergic encephalomyelitis. Eur. J. Immunol. 24, 1434-1440.
23. Severn, A., Rapson, N.T., Hunter, C.A., Liew, F.Y., 1992. Regulation of tumor necrosis factor production by adrenaline and β-adrenergic agonists. J. Immunol. 148, 3441-3445.
24. Spengler, R.N., Chensue, S.W., Giacherio, D.A., Blenk, N., Kunkel, S.L., 1994. Endogenous norepinephrine regulates tumor necrosis factor-α production from macrophages in vitro. J. Immunol. 152, 3024-3031.
25. Suberville, S., Bellocq, A., Fouqueray, B., Philippe, C., Lantz, O., Perez, J., Baud, L., 1996. Regulation of interleukin-10 production by β-adrenergic agonists. Eur. J. Immunol. 26, 2601-2605.
26. Szabó, C., Haskó, G., Zingarelli, B., Németh, Z.H., Salzman, A.L., Kvetan, V., Pastores, S.M., Vizi, E.S., 1997. Isoproterenol regulates TNF, IL-10, IL-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxemia. Immunology 90, 95-100.
27. Trinchieri, G., 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13, 251-276.
28. van der Poll, T., Coyle, S.M., Barbosa, K., Braxton, C.C., Lowry, S.F., 1996. Epinephrine inhibits tumor necrosis factor-α and potentiates interleukin 10 production during human endotoxemia. J. Clin. Invest. 97, 713-719.
29. van der Pouw Kraan, T.C.T.M., Boeije, L.C.M., Smeenk, R.J.T., Wijdenes, J., Aarden, L.A., 1995. Prostaglandin-E2 is a potent inhibitor of human interleukin-12 production. J. Exp. Med. 181, 775-779.
30. van der Pouw Kraan, T.C.T.M., Snijders, A., Boeije, L.C.M., de Groot, E.R., Leurs, R., Aarden, L.A., 1997. Histamine, through interaction with H2 receptors, and PGE-2 inhibit the production of human bioactive interleukin-12. Immunol. Lett. 56, 423, Suppl.
31. Wiegmann, K., Muthyala, S., Kim, D.H., Arnason, B.G.W., Chelmicka-Schorr, E., 1995. β-Adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats. J. Neuroimmunol. 56, 201-206.
32. Wysocka, M., Kubin, M., Vieira, L.Q., Ozmen, L., Garotta, G., Scott, P., Trinchieri, G., 1995. Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 25, 672-676.